Form 4: Prestige Consumer Healthcare Senior VP Sells Shares

Prestige Consumer Healthcare's Senior VP of Operations, Jeffrey Zerillo, sold 1,000 shares of common stock for $65.93 per share.

Summary

• Jeffrey Zerillo, Senior VP Operations of Prestige Consumer Healthcare Inc. (PBH), reported a transaction.
• The transaction involved the sale of 1,000 shares of Common Stock, par value $0.01 per share.
• The sale occurred on February 11, 2026, at a price of $65.93 per share.
• Following this transaction, Jeffrey Zerillo beneficially owns 41,048 shares of Common Stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While it's an insider sale, the transaction was pre-planned under a Rule 10b5-1 plan, which typically reduces the negative signaling effect compared to an unplanned open-market sale.

Negatives

• An insider, the Senior VP Operations, sold 1,000 shares of company stock.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales, even when pre-planned under Rule 10b5-1, represent a reduction in direct ownership by a key executive. While 10b5-1 plans mitigate the immediate signal of market timing, investors often monitor such transactions as part of a broader assessment of management's conviction and liquidity needs.

Stakeholder Impact

• Shareholders might view the insider sale as a minor, neutral to slightly negative signal, though the Rule 10b5-1 plan mitigates concerns about market timing.

Key Dates

Recommendation

A single insider sale of 1,000 shares by a Senior VP, especially when executed under a Rule 10b5-1 plan, is generally not a significant event to warrant a change in investment recommendation for a company of Prestige Consumer Healthcare's size. It's a routine liquidity event rather than a strong signal of fundamental change, thus a 'hold' recommendation remains appropriate.

Keywords

Prestige Consumer Healthcare, PBH, Insider Sale, Form 4, Jeffrey Zerillo, Stock Transaction, Senior VP Operations, Rule 10b5-1